Poster Abstracts 13Th International Conference on Myasthenia Gravis and Related Disorders Abstract List
13th International Conference on Myasthenia Gravis and Related Disorders POSTER SESSION MAY 15, 2017 | 6:00 PM New York Marriott Downtown Basic Science and Animal Models 1. Sonia Berrih-Aknin, DSc, Preconditioned Mesenchymal Stem Cells Treat Myasthenia Gravis in a Humanized Preclinical Model 2. Michelangelo Cao, MD, Specificity of Shp2 Inhibition on Acetylcholine Receptor Clustering 3. Hakan Cetin, MD, Fetal and Adult Acetylcholine Receptor Function and the Impact of Receptor Clustering 4. Leslie Jacobson, BSc, Dphil, AChR-antibody Mediated Arthrogryposis: Inhibition of Placental Transfer in a Mouse Model Protects the Fetus 5. Linda Kusner, PhD, Preclinical Pilot Study of Alpha-fetoprotein on Moderation of MG Weakness 6. Konstantinos Lazaridis, PhD, Antigen-specific Therapeutic Immunoadsorption Results in Amelioration of Experimental MG Symptoms 7. Christopher Meriney, BS, Lambert-Eaton Myasthenic Syndrome: Passive Transfer to Mice, Active Zone Structure-function Relationships, and Novel Treatment Strategies 8. David P. Richman, MD, Analysis of Muscle Wasting in an Acute Severe Model of Muscle-specific Kinase Antibody Myasthenia Gravis 9. Kazuhiro Shigemoto, MD, Mouse Model of Lrp4-MG 10. Jie Song, MD, ROCK Inhibitor Suppresses Experimental Autoimmune Myasthenia Gravis by Inhibiting Th1, Th17 and B-cells 11. Armineh Issakhanian Stoner, MS, The Potential Role of Anti-Lrp4 Autoantibodies in the pathogenesis of Myasthenia Gravis (MG) and Amyotrophic Lateral Sclerosis (ALS) 12. Erdem Tüzün, MD, MuSK-binding Peripheral B-cells as Biomarker for MuSK-Myasthenia Gravis 1 | Poster Abstracts 13th International Conference on Myasthenia Gravis and Related Disorders Abstract List 13. Adi Vaknin-Dembinsky, MD, PhD, Exacerbation of EAMG by NMO Antibodies or Aquaporin 4 Peptide 14.
[Show full text]